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ABSTRACT
Purpose The Vitamin D in Pregnancy Study is a long- 
term ongoing cohort study. It was conceived to explore 
relationships between maternal vitamin D status in 
pregnancy and offspring growth and development, and has 
since diversified to include a wide range of physical and 
mental health exposures and outcomes.
Participants Recruitment was from the University 
Hospital Geelong (Barwon Health) antenatal clinic, Geelong, 
Victoria, Australia, between 2002 and 2004. 475 women 
were initially recruited, which resulted in 400 eligible 
mother–child pairs at birth.
Findings to date The cohort has been followed up twice 
in pregnancy, at birth, and 1 year, 6 years and 11 years 
post birth. The study has reported an association between 
vitamin D in pregnancy and musculoskeletal health and 
body composition in the children.
Future plans Subject to funding, there will be a 
prospective young adult follow- up. This profile aims to 
foster both cross- national and international collaborations 
with both existing and future data collection.
INTRODUCTION
There is substantial evidence supporting 
the Developmental Origins of Health 
and Disease hypothesis which ties early- 
life exposures to an increased risk of non- 
communicable disease in adult life by means 
of ‘fetal programming’.1 Fetal programming 
represents the phenomenon by which nutri-
tional, environmental and genetic influences 
(such as epigenetic adaptation to maternal 
environment and paternal and intergener-
ational epigenetic transmission) influence 
fetal growth and development in utero, 
which, in turn, may permanently alter disease 
risk trajectories.2
Vitamin D status represents a modifiable 
and affordable target for nutritional interven-
tion during pregnancy. At the time of incep-
tion of the Vitamin D in Pregnancy (VIP) 
Study, and in more recent times, a signifi-
cant number of women residing in Australia, 
including those of childbearing age, recorded 
low serum vitamin D levels by currently 
accepted standards (<50 nmol/L).3 4 Subop-
timal levels of vitamin D during pregnancy 
is of concern not only for the mothers, but 
also because it exposes the developing fetus 
to insufficiency during critical phases of 
development, and thus may predispose the 
offspring to an increased risk of disease, such 
as rickets in infancy and childhood, and oste-
oporosis in adulthood.
The VIP Study was originally designed to 
investigate the potential role of vitamin D 
during pregnancy on infant bone develop-
ment and growth measures; however, based 
on a growing body of literature,5 6 the study 
has since expanded to encompass longi-
tudinal investigations of several aspects of 
offspring growth and development. Impor-
tantly, the VIP cohort was recruited at a time 
when vitamin D measurement and supple-
mentation were relatively uncommon in 
Australia, resulting in relatively high rates 
of maternal vitamin D deficiency.7 8 The 
study thus provides an important opportu-
nity to investigate the relationship between 
low maternal vitamin D status and offspring 
outcomes.
The aims of the study are to identify 
whether maternal vitamin D insufficiency 
during pregnancy is associated with the 
following outcomes in the offspring:
1. Bone growth, density and mineral content.
2. Muscle mass and strength.
Strengths and limitations of this study
 ► Pregnant women had measures taken at two time 
points in pregnancy, which allows for the exam-
ination of temporal factors with relevant exposures 
during pregnancy.
 ► There has been many follow- ups of both mother and 
children across time and a wide range of exposure 
and outcome variables collected.
 ► The study is observational in nature; thus, residual 
confounding cannot be discounted.
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3. Adiposity.
4. Atopic and respiratory symptoms.
5. Behaviour and psychological symptomatology.
The study design of the VIP cohort will contribute infor-
mation to the growing policy debate surrounding vitamin 
D supplementation and sun exposure during pregnancy 
to alleviate chronic disease burden in the offspring.
This cohort profile aims to describe the methods, 
recruitment phases, breadth and scope of the data 
collected to date and future plans of the cohort to 
external researchers to facilitate collaboration. The chil-
dren will begin turning 18 years of age from September 
2020, at which point we will plan to embark on a young 
adult follow- up.
COHORT DESCRIPTION
Patient and public involvement
No patient involved.
Participants
In total, 475 pregnant women were recruited prior to 16 
weeks gestation from the antenatal clinic at the Univer-
sity Hospital Geelong (formerly known as the Geelong 
Hospital), in south- eastern Australia (latitude: −38.15). 
This recruitment target was based on the assumption, 
using a conservative estimate of 4.2% of women having 
vitamin D levels below 28 nmol/L, that with 360 women 
there would be 80% power to detect a 0.75 SD in knee–
heel length in babies above and below 28 nmol/L vitamin 
D. Assuming 20% attrition, 450 women would have to be 
targeted. A further 25 women were recruited to allow for 
failure to provide a blood sample at the off- site testing facil-
ities. At the time of recruitment, the University Hospital 
Geelong served as the sole public teaching hospital in the 
region. Recruitment took place over an 18- month period 
and was completed in 2004. During the recruitment 
period, the population in the Barwon Statistical Division 
was approximately 260 000. There were an estimated 2470 
women who registered for antenatal care at the University 
Hospital Geelong during the study period. Inclusion and 
exclusion criteria are presented in table 1. At birth, 400 
mother–child pairs had data recorded, with a maternal 
serum 25- hydroxyvitamin D (25(OH)D) concentration 
measured in early and/or late pregnancy. At recruitment 
169/415 (40.7%) women, and at 28–32 weeks gestation 
148/380 (38.9%) women had 25(OH)D serum level 
below 50 nmol/L, respectively.
Data collection and methodology
Following baseline recruitment, which occurred before 16 
weeks gestation, mothers were reassessed at 28–32 weeks 
gestation, and mother–child pairs underwent follow- up 
appointments once the offspring were born, with subse-
quent clinical assessments at 12 months and 11 years post 
birth (figure 1). There were 209 of the 475 (44%) women 
recruited who returned at the 11- year follow- up. There 
were no differences between vitamin D levels at either 
time point, smoking status during pregnancy, height, 
weight, parity or education detected for non- responders 
versus responders. Mothers who participated in the 
11- year follow- up were slightly older at recruitment than 
non- responders (29.65±4.34 (responders) vs 28.71±4.10 
(non- responders) years, p=0.049).
When offspring were approximately 5 years of age 
(n=342, 92% of those eligible), telephone interviews 
were conducted with women who had a vitamin D sample 
taken during late pregnancy. Additionally, in a substudy 
conducted after the telephone interviews, lung function 
was tested in a selection of children 5 years post birth 
whose mothers were in the highest or lowest quartile of 
vitamin D at 28–32 weeks gestation (n=58). Participant 
characteristics at each follow- up are listed in table 2.
Throughout the study, a series of clinical and question-
naire data has been collected from both parents, and 
offspring; these data are briefly described below. Table 3 
presents the schedule of data collection at each time 
point. Where possible, self- reported health outcomes 
which would require hospital admission were verified 
with (1) medical records from the University Hospital 
Geelong and (2) the comprehensive fracture register for 
the Barwon Statistical Division, known as the Geelong 
Osteoporosis Study Fracture Grid.9
Maternal data
Blood collection
Maternal venous blood samples were taken at recruit-
ment and 28 weeks gestation. Serum samples were 
centrifuged within 2 hours and stored at −70°C. Samples 
were analysed for 25(OH)D by radioimmunoassay 
(Immunodiagnostic Systems, Tyne and Wear, UK); coef-
ficient of variation at 30 nmol/L was 10.2%, and 10.1% 
Table 1 Inclusion and exclusion criteria for recruitment of pregnant mothers into the study
Inclusion criteria Exclusion criteria
1. Singleton pregnancy
2. Over the age of 18 years
3. Gestational age of less than 16 weeks
4. Unlikely to leave the area within the foreseeable future
1. Evidence of insulin- dependent diabetes, anticonvulsant 
therapy, renal disease
2. Sarcoidosis or familial hypocalciuric hypercalcaemia
3. Substance use/abuse
4. Maintenance systematic or high- dose glucocorticoid therapy
5. Significant maternal illness and/or disability
6. Dark skinned and/or veiled (as of known high risk for deficiency 
and usually screened and treated)
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at 100 nmol/L, parathyroid hormone by chemilumines-
cent enzyme- labelled immunometric assay (Diagnostic 
Products Corporation, Los Angeles, California, USA) 
and total calcium and albumin using Vitros 250 autoan-
alyzer (Ortho- Clinical Diagnostics, Rochester, New York, 
USA).
Anthropometry, other clinical measures and demographics
Maternal body weight (±0.1 kg) was measured with elec-
tronic scales and height (±0.1 cm) ascertained by use of 
a wall- mounted stadiometer at recruitment, 28 weeks 
gestation and at the follow- up performed 11 years post 
birth of their offspring. Clinical measures included head 
circumference at recruitment, and hip and waist circum-
ferences at 11 years post birth of their offspring. Blood 
pressure during pregnancy was extracted from patient 
obstetric records. Area- based socioeconomic status was 
calculated by matching the residential address of each 
participant at baseline recruitment, and of the mother 
at 11 years post birth, to the corresponding Australian 
Bureau of Statistics (ABS) Census Collection District 
(each area that encompasses approximately 250 house-
holds). Using ABS software, Socio- Economic Indexes 
for Areas values were determined from the 2001 census 
for residential addresses at baseline, and from the 2016 
census for addresses at 11 years post birth.10 11 Infor-
mation on educational attainment, employment status, 
occupation type, living arrangements (home owner-
ship and how many occupants in the home), marital 
status and country of birth was collected by self- report 
(table 3).
Bone measures
Quantitative heel ultrasound was performed at the 
11 years follow- up using a Lunar Achilles ultrasonometer 
(GE, Madison, USA) on the left foot, to obtain measures 
of broadband attenuation, speed of sound and stiffness 
index as measures of bone quality.
Figure 1 Participation rates at clinical follow- up 
assessments.
Table 2 Participant characteristics at each clinical follow- up of the Vitamin D in Pregnancy Study
Characteristic At birth n=402 12 months post birth n=376 11 years post birth n=209
Maternal
  Age (year) 29.7 (±0.4.72) 30.9 (±4.73) 41.4 (±4.40)
  Height (cm)* 165.0 (161.0–172.0) – 165.2 (±5.96)
  Weight (kg)* 76.65 (68.60–88.15) – 74.5 (64.03–89.78)
Offspring
  Sex n (%) males 196 (48.9) 188 (50.0) 106 (50.7)
  Age (year) – 1.00 (0.98–1.04) 10.92 (10.71–11.39)
  Length/height (cm) 50.50 (48.80–52.00) 76.96 (±3.12) 147.45 (143.43–154.25)
  Weight (kg) 3.54 (±0.53) 9.97 (±1.27) 40.05 (35.00–48.25)
Data are presented as median (IQR) or mean (±SD).
*Measures under at birth were collected at 28–32 weeks gestation visit.
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Table 3 Schedule of measurements collected at each follow- up appointment of the Vitamin D in Pregnancy Study
Recruitment
28–32 weeks 
gestation At birth
12 months 
post birth
5 years post 
birth
11 years 
post birth
Maternal measures             
  Blood sample X X         
  Anthropometric X X       X
  Sociodemographic X X       X
  Medication/supplement use X X         
  Diet X X       X
  Smoking status X X       X
  Skin type X X         
  Sun exposure X X         
  Obstetric data X X X       
  Mental health           X
  Bone measures           X
  Health literacy           X
Paternal measures             
  Anthropometric X           
  Sociodemographic X         X
  Smoking Status X         X
Child measures             
  Anthropometric     X X X X
  Fetal ultrasound measures   X         
  Sociodemographic     X X X X
  Medication/supplement use       X X X
  Breast feeding       X     
  Diet       X X X
  Blood testing     X       
  Body composition     X X   X
  Bone measures           X
  Self- reported fracture           X
  Muscle strength           X
  Allergy/eczema symptoms       X X X
  Asthma/wheezing symptoms       X X X
  Spirometry       X X   
  General health       X X X
  Immunisations         X X
  Physical activity         X X
  Sun exposure         X X
  Dental history             
  Sleeping habits           X
  Screen time         X X
  Skin type         X X
  Living arrangements         X X
  Mental health           X
  Hygiene         X   
X denotes that the relevant measurement was collected at the noted follow- up phase.
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Health behaviours
Maternal skin pigmentation on the back of hands, inner 
underarm and shoulder, was determined using a flash 
spectrophotometer at recruitment and at 28–32 weeks 
gestation. Maternal sun exposure was self- reported as time 
spent outdoors in the sun and sunbathing behaviours 
were concurrently recorded.
Maternal smoking status was self- reported at baseline 
recruitment and at the 5- year and 11- year follow- up assess-
ments. In addition, the number of occupants smoking in 
the main residence and the number of cigarettes smoked 
by each individual were reported by the mother.
Maternal dietary macro and micronutrient and alcohol 
intakes were recorded at recruitment, 28–32 weeks gesta-
tion and at 11 years using the Victorian Cancer Council 
Food Frequency Questionnaire.12
Maternal health literacy was measured at 11 years using 
the Health Literacy Questionnaire (HLQ).13 The HLQ 
is a multidimensional tool that measures nine specific 
domains: healthcare provider support, access to sufficient 
health information, ability to actively manage health, 
social support, level of critical appraisal, level of active 
engagement with healthcare providers, ability to navigate 
the healthcare system, ability to find quality health infor-
mation and comprehension of health information.
Mental health
Maternal mental health status was assessed using semi-
structured clinical interviews at 11 years. The Struc-
tured Clinical Interview for Diagnostic and Statistical 
Manual of Mental Disorders (DSM) Axis I Disorders, 
non- patient edition (SCID- I/NP) was used to obtain 
diagnoses for current and past mood, anxiety, alcohol 
and non- alcohol substance misuse, and eating disor-
ders.14 Personality disorders were identified using the 
Structured Clinical Interview for DSM- IV Axis II person-
ality disorders (SCID- II).15 The Perinatal Grief Scale was 
also completed by the mothers at 11 years to determine 
factors that may be important with the relationship 
between mother and her living children after the loss 
of a child.16
Paternal data
Fathers self- reported their height (±cm), weight (±kg) 
and head circumference (±cm) at baseline recruitment. 
Sociodemographic information, including living arrange-
ments, employment status, occupation type and educa-
tional attainment, was collected at recruitment and 11 
years. Smoking status was recorded at recruitment and 11 
years.
Offspring data
Blood sample
DNA was extracted from the offspring’s blood spot 
on their Guthrie card sample to determine vitamin 
D receptor genotype using Chelex reagent (BioRad, 
Hercules, California, USA).
Anthropometry and other clinical measures
At birth, weight was measured by obstetric staff on regu-
larly calibrated scales (±1 g). Crown- heel length was 
measured using a length board (Ellard Instrumentation, 
Seattle, Washington, USA) and knee–heel length to the 
nearest millimetre using a hand- held BK5 knemom-
eter (Force Technology, Brondby, Denmark) within 
12–72 hours post birth. At 12 months and 11 years post 
birth, offspring body weight (±0.1 kg) was measured with 
electronic scales and height (±0.1 cm) collected by use 
of a wall- mounted stadiometer. Skinfold measurements 
were collected at various sites at birth, 12 months and 
11 years in the offspring, according to International 
Society for the Advancement of Kinanthropometry 
protocol using Holtain calipers (±0.1 mm; Holtain, 
Crymych, UK).17 Mid- arm, calf and head circumferences 
were collected at birth, 12 months and 11 years, with 
the addition of hip and waist circumferences at 11 years. 
Triplicate blood pressure was measured at 12 months 
(Critikon Dinamap Pro 100 oscillometric device, GE 
Healthcare, UK), and at 11 years using a digital metre 
(A&D Company). Muscle strength was measured at 11 
years by use of a manual muscle tester (Nicholas, Model 
01163), and grip strength using a hand- held dynamom-
eter (JAMAR Plus Digit). Balance and explosive force 
were measured in a subset of participants (n=13) by use 
of a Ground Reaction Force Platform (Leonardo). Self- 
reported pubertal staging was completed using Tanner 
staging at 11 years18.19
Bone and body composition measures
Bone densitometry was performed for each child at age 
11 years by dual energy x- ray absorptiometry (DXA) 
using a Lunar Prodigy densitometer (GE Lunar, Madison, 
Wisconsin, USA) at the lumbar spine (L1–4), forearm 
and total body). From the total body scans, total and 
regional fat and non- bone lean tissue mass was obtained. 
Trabecular bone score was calculated from spine scans 
(iNsight, V.2.1, Med- Imaps). Quantitative heel ultrasound 
was also performed (Achilles Insight, GE Lunar). In a 
subset of participants (n=13), bone density and geometry 
were measured by peripheral quantitative CT (XT3000, 
Stratec, Pforzheim, Germany) at 11 years at the forearm 
and proximal femur. At the time of writing, the identifi-
cation of incident fractures up to the age of 16 years was 
being completed via a previously validated method using 
radiological reports.9
Allergy, wheezing and asthma
Wheezing and doctor- diagnosed asthma and eczema in 
the offspring were self- reported by the mothers when the 
children were aged 12 months. The International Study 
of Asthma and Allergies in Children questionnaire was 
completed by the mothers at 5 and 11 years.20 Spirometry 
was conducted in a subsample of offspring at age 5 years, 
and for all the offspring at 11 years, using processes in 
accordance with the American Thoracic Society guide-
lines.21 22
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Health behaviours
Information about sun exposure, skin type and sunburn 
history of the offspring was collected at 5 and 11 years. 
Additionally, a naevi count was performed at 11 years 
of age, whereby higher naevi counts were indicative of 
higher past sun exposure.23
Physical activity was documented at 5 years by recording 
how much time was spent on sporting activities. At 11 
years, activity was recorded using an after- school diary.24 
This diary recorded activity for a 2 hours period, 3 days 
after school on a scale of resting/sleeping to intense 
activity. Breastfeeding status and age of introduction to 
solids were recorded at 12 months. At 5 years of age, 
intake of vitamin D- rich food sources, such as oily fish, 
was recorded by questionnaire, and at 11 years dietary 
patterns were assessed using the Children’s Dietary 
Questionnaire.25
All health behaviour measures were maternally reported 
on behalf of the child.
Mental health
Behaviour and mental health symptomatology of the 
offspring were assessed at 11 years. Self- reported psycho-
logical symptoms were identified using the Spence Chil-
dren’s Anxiety Scale,26 psychotic life exposures and the 
Short Mood and Feelings Questionnaire.27 Mothers 
provided informant responses on the Strengths and Diffi-
culties Questionnaire, which assessed emotional, internal-
ising and externalising symptoms and behaviours28 and 
the Australian Scale for Asperger’s syndrome to identify 
behaviours and abilities that typify Asperger's Syndrome 
during childhood.
Future plans
Subject to obtaining funding, we will be seeking to embark 
on a follow- up of the offspring in young adulthood. The 
primary focus of this follow- up will align with the original 
focus of maternal vitamin D status in pregnancy offspring 
growth and development.
FINDINGS TO DATE
Data generated from the VIP cohort have been published 
in peer- reviewed journals, and presentations made at 
national and international scientific meetings. We have 
reported several findings with relation to our primary 
exposures and outcomes. Specifically, that maternal 
vitamin D levels were:
 ► Positively associated with knee–heel length at birth 
(a proxy measure of long bone growth in utero), 
mid- upper arm and calf circumference and gestation 
length.29
 ► Positively associated with bone mineral density of the 
spine and total body at 11 years in boys but not in 
girls.30
 ► Negatively associated with total fat mass pecentage and 
positively associated with total lean mass percentage at 
11 years in offspring whose mothers also smoked.31
 ► Positively associated with trabecular bone scores at 11 
years in boys, but not girls.32
Moreover, we have reported that infant vitamin D 
receptor genotype potentially plays a role in the associa-
tion between low maternal vitamin D status and offspring 
birth measures.33 Pregnant women were shown to be 
more likely to consume more calcium and phosphorus 
through diet than non- pregnant peers in late pregnancy; 
this was not detected for other important nutrients with 
an increased demand.34 Maternal diet was shown to be 
associated with offspring linear growth, but not with 
bone measures at 11 years.35 Analyses with other health 
outcomes such as respiratory, atopic and behavioural 
measures are ongoing, and investigators encourage 
collaboration from researchers with these particular 
interests.
Strengths and limitations
The major strengths of this project are that data were 
collected during two stages of pregnancy (prior to 16 
weeks, and at 28–32 weeks gestation), and that at the time 
of recruitment, maternal vitamin D insufficiency was rela-
tively common. Furthermore, the prospective study design 
enables us to discern temporal associations between expo-
sures during both early and late stages of pregnancy and 
offspring outcomes ranging from birth to 11 years of age. 
The Barwon Statistical Division, from which the study 
population was drawn, is comparable to the wider Austra-
lian population, thus enhancing the generalisability of 
findings at a national level.36 At the 2001 ABS census, the 
Barwon Statistical Division was similar to the wider Austra-
lian population in terms of age (0.7% difference), marital 
status (2.2%), weekly income (1.4%) and school leavers’ 
age (7.5%). As we recruited from a publicly funded 
hospital, our sample may be relatively more disadvan-
taged than mothers in the region who accessed prenatal 
care via private options. A further consideration is that 
the majority of our sample is Caucasian given the relative 
lack of ethnic diversity within the region and the exclu-
sion of dark skinned or veiled women, thus impacting the 
generalisability of the findings from this cohort. This may 
decrease the ability to extrapolate findings to the broader 
international community but assist with internal validity. 
The ethnic homogeneity, however, has advantages, in that 
it reduces potential for confounding by biological and 
genetic differences in both the exposure (eg, vitamin D 
metabolism) and outcomes (eg, bone mineral density). 
In comparison to some of the larger birth cohorts such 
as the Hertfordshire Cohort Study,37 400 mother–child 
pairs could be considered a relatively small number that 
may limit statistical power to test for associations in less 
prevalent outcomes. However, unlike larger studies, the 
VIP encompasses significantly detailed prospective infor-
mation and blood samples, and thus does not rely on 
proxy measures or recalled information for exposures 
during pregnancy. There are other cohorts such as the 
Southampton Women’s Study,38 Avon Longitudinal Study 
of Parents and Children,39 Raine Study40 and Generation 
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R Study41 that have collected both gestational vitamin 
D levels and child DXA measures. However, this study 
differentiates itself from with the others by objectively 
measuring gestational vitamin D, as serum 25(OH)
D, at two defined time points in pregnancy. There has 
also been considerable attrition from recruitment to the 
recent 11 year follow- up. However, the remaining partic-
ipants appeared to be largely representative in terms of 
maternal measures as those who did not attend the 11- year 
follow- up, although they were slightly older; these find-
ings suggest a non- differential loss to follow- up in terms 
of maternal characteristics. Lastly, given the observational 
design, there is the possibility for residual confounding 
that is unaccounted for.
COLLABORATION
Data are archived by the Epi- Centre for Healthy Ageing, 
Deakin University and Barwon Health, located at Univer-
sity Hospital Geelong (Barwon Health). Collaborations 
are encouraged and data requests can be sent to the prin-
ciple investigator Professor Julie Pasco ( juliep@ barwon-
health. org. au). Establishment of collaborative projects 
will be overseen by the VIP research group and the 
Barwon Health Human Research Ethics Committee. All 
participants in the study have provided written informed 
consent on behalf of themselves and their children: 
additionally at the 11- year follow- up, children provided 
optional assent.
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